The North America Bioinformatics Market is witnessing robust expansion driven by increasing demand for precision medicine, rising investments in healthcare IT, and strong adoption of AI technologies. The market is expected to grow from USD 9,800 Million in 2025 to USD 21,500 Million by 2035, registering a CAGR of 7.9% from 2024 to 2035.
The economic impact of tariffs on "North America Bioinformatics Market".
Market Growth Drivers
Rising adoption of precision medicine has significantly fueled the North American bioinformatics market. Companies such as Illumina have expanded their sequencing platforms, facilitating the analysis of large datasets that enable tailored medical treatment. The integration of genomics data into patient care drives the demand for bioinformatics solutions in clinical diagnostics and drug discovery, enhancing patient outcomes and reducing healthcare costs.
Increasing investments in healthcare IT and genomic research are accelerating growth. Companies like Thermo Fisher Scientific have launched new cloud-based analytics platforms and invested heavily in bioinformatics R&D. These initiatives foster the development of cutting-edge software for data management and interpretation, making bioinformatics tools more accessible to research institutions and healthcare providers across North America.
Market Trends
Integration of artificial intelligence and machine learning into bioinformatics workflows is transforming the industry. For example, DNAnexus has pioneered AI-powered platforms for large-scale genomic analysis, enabling rapid interpretation of complex datasets for pharmaceutical, biotech, and clinical applications. This trend is enhancing the accuracy of predictive models and providing actionable insights for drug development and personalized medicine.
Expansion of cloud-based bioinformatics platforms is streamlining collaboration and data sharing across organizations. Companies like QIAGEN have introduced scalable cloud ecosystems that facilitate remote access to bioinformatics tools and databases. This trend supports multi-institutional research projects and accelerates the pace of innovation by enabling seamless data integration and workflow automation.
Market Opportunities
Emerging applications in agricultural genomics present substantial opportunities for bioinformatics providers. Firms such as AgriGenome are leveraging bioinformatics for crop improvement, pest resistance, and yield optimization, expanding the market beyond healthcare into agritech.
The growing use of bioinformatics in drug repurposing is creating new business avenues. For instance, companies like Recursion Pharmaceuticals are using advanced computational platforms to identify new therapeutic uses for existing drugs, helping to accelerate drug discovery pipelines.
North America Bioinformatics Market Revenue (USD Million), 2020-2035
The chart displays a steady upward trajectory of the North America Bioinformatics Market from 2020 through 2035. The market was valued at USD 5,200 Million in 2020 and showed consistent growth, reaching USD 9,800 Million in 2025. Driven by advancements in genomics, AI, and cloud technologies, the market is projected to surge to USD 21,500 Million by 2035. The CAGR of 7.9% indicates strong long-term demand, particularly as research, clinical, and agricultural sectors continue to adopt bioinformatics solutions for diverse applications.
North America Bioinformatics Market Share by Region (%), 2025
The 2025 market share pie chart highlights the dominance of the United States, which accounts for approximately 74% of the North American bioinformatics market. Canada follows with 20% and Mexico captures 4%. The rest of North America, including smaller economies and territories, constitutes a minor percentage. The significant share of the U.S. is attributed to its advanced healthcare infrastructure, strong presence of bioinformatics companies, and substantial R&D funding, while Canada shows notable growth driven by government genomics initiatives.
Recent Developments in North America Bioinformatics Market
In April 2024, Illumina launched a new AI-based bioinformatics platform designed to enhance clinical genomic analysis. This platform integrates machine learning to interpret genomic variants faster and more accurately, supporting precision oncology projects in collaboration with major North American health networks.
In March 2024, Thermo Fisher Scientific announced a partnership with Microsoft Azure to further expand its cloud-based bioinformatics data management solutions. The collaboration aims to leverage Azure's scalable cloud infrastructure to deliver secure, high-throughput data processing capable of supporting national-scale genomics initiatives.
In February 2024, DNAnexus unveiled its latest multi-omics integration toolkit, which allows researchers and clinical labs in North America to combine genomics, transcriptomics, and proteomics data into unified analyses. This launch addresses the growing demand for integrated multi-omics solutions in both academic research and drug discovery.
Press Releases